Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04276324
Other study ID # UCAM
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 10, 2020
Est. completion date October 15, 2020

Study information

Verified date October 2020
Source Universidad Católica San Antonio de Murcia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Multiple Sclerosis (ME) is a degenerative, inflammatory and autoimmune demyelinating disease of the central nervous system, characterized by demyelination due to inflammation and degeneration of the myelin sheaths enveloping nerves of the eye, periventricular grey matter, brain, spinal cord and brainstem. The symptoms associated with MS include symptomatic fatigue, muscle weakness, ataxia, mobility and balance problems or cognitive problems. Strength training has been shown to improve strength and mobility in persons with MS.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date October 15, 2020
Est. primary completion date June 15, 2020
Accepts healthy volunteers No
Gender All
Age group 20 Years to 60 Years
Eligibility Inclusion Criteria: - mild or moderate disability with clinical mild spastic-ataxic gait disorder. - stable phase of the disease. Exclusion Criteria: - Expanded Disability Status Scale (EDSS) < 6. - relapsing disease within the preceding 12 months. - corticosteroid treatment within the last months before study inclusion.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Resistance training
Ten weeks of resistance training
Testing sessions
Testing sessions

Locations

Country Name City State
Spain Universidad Católica San Antonio Murcia

Sponsors (1)

Lead Sponsor Collaborator
Universidad Católica San Antonio de Murcia

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Maximal Voluntary Isometric Contraction of Knee Extension Before the program training
Primary Maximal Voluntary Isometric Contraction of Knee Extension After 10 weeks
Primary Rate of Force Development Before the program training
Primary Rate of Force Development After 10 weeks
Primary Central Activation Ratio Before the program training
Primary Central Activation Ratio After 10 weeks
Primary Spasticity Pendulum test Before the program training
Primary Spasticity Pendulum test After 10 weeks
Secondary Walking speed Test 10 m-walks Before the program training
Secondary Walking speed Test 10 m-walks After 10 weeks
Secondary Static balance Romberg Test with eyes open and closed. Analysis with force plates Before the program training
Secondary Static balance Romberg Test with eyes open and closed. Analysis with force plates After 10 weeks
Secondary Functional capacity Sit to stand test Before the program training
Secondary Functional capacity Sit to stand test After 10 weeks
Secondary Heart Rate Variability Sleeping Heart Rate Variability Before the program training
Secondary Heart Rate Variability Sleeping Heart Rate Variability After 10 weeks
Secondary Sleep Quality Karolinska Sleep Diary and Acelerometry Before the program training
Secondary Sleep Quality Karolinska Sleep Diary and Acelerometry After 10 weeks
See also
  Status Clinical Trial Phase
Completed NCT05528666 - Risk Perception in Multiple Sclerosis
Completed NCT03608527 - Adaptive Plasticity Following Rehabilitation in Multiple Sclerosis N/A
Recruiting NCT05532943 - Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis Phase 1/Phase 2
Completed NCT02486640 - Evaluation of Potential Predictors of Adherence by Investigating a Representative Cohort of Multiple Sclerosis (MS) Patients in Germany Treated With Betaferon
Completed NCT01324232 - Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis Phase 2
Completed NCT04546698 - 5-HT7 Receptor Implication in Inflammatory Mechanisms in Multiple Sclerosis
Active, not recruiting NCT04380220 - Coagulation/Complement Activation and Cerebral Hypoperfusion in Relapsing-remitting Multiple Sclerosis
Completed NCT02835677 - Integrating Caregiver Support Into MS Care N/A
Completed NCT03686826 - Feasibility and Reliability of Multimodal Evoked Potentials
Recruiting NCT05964829 - Impact of the Cionic Neural Sleeve on Mobility in Multiple Sclerosis N/A
Withdrawn NCT06021561 - Orofacial Pain in Multiple Sclerosis
Completed NCT03653585 - Cortical Lesions in Patients With Multiple Sclerosis
Recruiting NCT04798651 - Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis N/A
Active, not recruiting NCT05054140 - Study to Evaluate Efficacy, Safety, and Tolerability of IMU-838 in Patients With Progressive Multiple Sclerosis Phase 2
Completed NCT05447143 - Effect of Home Exercise Program on Various Parameters in Patients With Multiple Sclerosis N/A
Recruiting NCT06195644 - Effect of Galvanic Vestibular Stimulation on Cortical Excitability and Hand Dexterity in Multiple Sclerosis Patients Phase 1
Completed NCT04147052 - iSLEEPms: An Internet-Delivered Intervention for Sleep Disturbance in Multiple Sclerosis N/A
Completed NCT03591809 - Combined Exercise Training in Patients With Multiple Sclerosis N/A
Completed NCT03594357 - Cognitive Functions in Patients With Multiple Sclerosis
Completed NCT02845635 - MS Mosaic: A Longitudinal Research Study on Multiple Sclerosis